Page 136 | Certara

Publication

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…

CertaraJuly 15, 2020

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

CertaraJuly 14, 2020

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

CertaraJuly 14, 2020

Blog

Understanding the Duplicate Records Validation Rules

In this blog, we clarify the meaning & purpose of the duplicate records validation rules,…

CertaraJuly 7, 2020

SDTM Supplemental Qualifiers - blog post by Certara

On-Demand Webinar

The supplementary domain in SDTM: good, bad and ugly

All you need to know about the supplementary domain in SDTM The supplementary domain in…

CertaraJuly 2, 2020

Publication

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

CertaraJune 28, 2020

On-Demand Webinar

Simcyp: 20 Years of Innovation

CertaraJune 27, 2020

Case Study

Reimbursement and Launch Planning

CertaraJune 22, 2020

Brochure

Phoenix PK/PD Platform

CertaraJune 22, 2020

On-Demand Webinar

GlobalSubmit WebReview Key Features

CertaraJune 22, 2020

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Understanding the Duplicate Records Validation Rules

The supplementary domain in SDTM: good, bad and ugly

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

Simcyp: 20 Years of Innovation

Reimbursement and Launch Planning

Phoenix PK/PD Platform

GlobalSubmit WebReview Key Features

Newsletter sign up

Quick links

Solutions

Contact